Sign up for a new account.
And get access to
The latest T1D content
Research that matters
Our daily questions
Sign up by entering your info below.
Reset Your Password
We will email you instructions to reset your
Objective: To describe perceived burdens and benefits of continuous glucose monitor (CGM) use in CGM non-users vs. users with type 1 diabetes across the lifespan.
Research Design and Methods: The Burdens of CGM (BurCGM) and Benefit of CGM (BenCGM) questionnaires were completed at clinic visits from Feb 2019 to Nov 2019. Mean scores were calculated (scale 1-5; higher score reflects greater perceived burdens and benefits). Data collected from medical records included demographic information, CGM and insulin pump use, and HbA1c within 3 months of the visit.
Results: Participant characteristics (n=1143) and the 3 most common perceived CGM burdens (in non-CGM users) and benefits (in non-CGM users and CGM users) are shown in the Table. Individuals using real time (RT) and non-RT CGM described more benefits (mean scores 34.9 and 34.0) when compared to those who never used CGM (mean score 30.2) (p<.001). There were no differences in burdens or benefits by sex or race. Mean HbA1C was lower in CGM users (8.2%) vs. non-CGM users (mean A1c 9.3%; p<.001); 47.4% of non-CGM users vs. 29.3% of RT-CGM users and 30.6% of non-RT-CGM users had A1c>9.0%.
Multi-center quality improvement collaborative: improving insulin pumps for patients with type 1 diabetes in the U.S.
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Join our mailing list for more about T1D